愛康醫療(01789.HK)年度純利增長84.2%至2.67億元 末期息7.5港仙
格隆匯3月23日丨愛康醫療(01789.HK)發佈年度業績,截至2019年12月31日止年度,公司實現收入9.27億元(人民幣,下同),同比增長54.3%;公司權益股東應占年度溢利2.67億元,同比增長84.2%;基本每股盈利0.26元;擬派末期股息每股7.5港仙。
公告表示,2019年度,集團繼續保持快速的增長,實現收入9.267億元,較2018年大幅增長54.3%。收入的大幅增長主要得益於(i)公司藉助3D打印技術和3DACT平台樹立公司的品牌形象,並運用其品牌形象取得額外市場份額;(ii)利用國際學術資源積極開拓集團的市場;及(iii)由於需求不斷增加,關節手術在中國內地更多的醫院內進行,因而有效地推動了3D打印產品和常規髖膝關節產品的銷售。
此外,集團2019年度的淨利潤亦較2018年大幅增加84.2%,歸因於收入增加,加上規模經濟效應以及採取有效的成本和費用控制措施所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.